Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence and incidence of cancer in animals
3.2.1.2 Technological advancements in pet cancer treatment
3.2.1.3 Growing research and investments in pet cancer therapy
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of cancer treatment and procedures
3.2.2.2 Adverse effects of drugs used for pet cancer treatment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Cancer Diagnostics & Treatment, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Diagnosics
5.2.1 By type
5.2.1.1 Imaging
5.2.1.2 Biopsy
5.2.1.3 Endoscopy
5.2.1.4 Other diagnostics
5.2.2 By end-use
5.2.2.1 Veterinary hospitals & clinics
5.2.2.2 Diagnostics centers
5.2.2.3 Other end-users
5.3 Treatment
5.3.1 By type
5.3.1.1 Surgery
5.3.1.2 Radiotherapy
5.3.1.3 Chemotherapy
5.3.1.4 Immunotherapy
5.3.1.5 Other treatments
5.3.2 By end-use
5.3.2.1 Veterinary hospitals
5.3.2.2 Veterinary clinics
5.3.2.3 Other end-users
Chapter 6 Market Estimates and Forecast, By Animal Type, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Canine
6.3 Feline
6.4 Equine
6.5 Other animal types
Chapter 7 Market Estimates and Forecast, By Cancer Type, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Mast cell tumors
7.3 Mammary tumors
7.4 Lymphomas
7.5 Melanoma
7.6 Other cancer types
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 AB Science
9.2 Accuray Incorporated
9.3 Boehringer Ingelheim International GmbH
9.4 Elanco
9.5 Karyopharm Therapeutics, Inc
9.6 NIPPON ZENYAKU KOGYO CO., LTD
9.7 PetCure Oncology
9.8 Regeneus Ltd
9.9 Varian Medical Systems, Inc
9.10 Virbac Corporation
9.11 Zoetis Services LLC
